ARK Genomic Revolution ETF (BATS:ARKG) Sets New 1-Year High – Here’s Why

Shares of ARK Genomic Revolution ETF (BATS:ARKG) hit a new 52-week high during trading on Monday . The company traded as high as $42.34 and last traded at $42.08, with a volume of 655870 shares traded. The stock had previously closed at $41.43.

ARK Genomic Revolution ETF Price Performance

The stock has a 50 day moving average price of $32.38 and a two-hundred day moving average price of $30.33.

Institutional Investors Weigh In On ARK Genomic Revolution ETF

Hedge funds have recently bought and sold shares of the company. Ascentis Independent Advisors bought a new position in ARK Genomic Revolution ETF during the first quarter worth about $26,000. PNC Financial Services Group Inc. lifted its position in ARK Genomic Revolution ETF by 53.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock worth $29,000 after buying an additional 378 shares in the last quarter. Sunbelt Securities Inc. boosted its position in ARK Genomic Revolution ETF by 734.3% during the third quarter. Sunbelt Securities Inc. now owns 1,118 shares of the company’s stock valued at $31,000 after purchasing an additional 984 shares during the last quarter. Western Wealth Management LLC acquired a new stake in shares of ARK Genomic Revolution ETF in the 1st quarter valued at approximately $37,000. Finally, Strategic Wealth Investment Group LLC acquired a new stake in ARK Genomic Revolution ETF in the second quarter valued at $38,000.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.